Lexaria Bioscience Corp. SEC filings LEXX
Lexaria Bioscience Corp. has 1,000 filings in SEC EDGAR's recent list, going back to Aug 25, 2009. Its latest annual report, Form 10-K, was filed on Nov 28, 2025 for the period ended Aug 31, 2025. The latest quarterly report (Form 10-Q) was filed on Jul 13, 2026, covering the quarter ended May 31, 2026. The most recent current report (Form 8-K) was filed on Sep 9, 2026 (material agreement, unregistered share sale, regulation fd disclosure). The company's fiscal year ends on August 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Oct 13, 2026 | — |
| 424B3 | Prospectus | Oct 13, 2026 | — |
| S-3 | Shelf registration | Oct 2, 2026 | — |
| D | Filing | Sep 21, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Sep 9, 2026 | Sep 7, 2026 |
| 8-K |
Current report
Other events
|
Sep 1, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Other events
|
Aug 17, 2026 | Aug 17, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 10, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jul 30, 2026 | Jul 29, 2026 |
| 10-Q | Quarterly report | Jul 13, 2026 | May 31, 2026 |
| 10-Q | Quarterly report | Apr 13, 2026 | Feb 28, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 8-K |
Current report
Listing notice
|
Feb 6, 2026 | Feb 4, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jan 28, 2026 | Jan 27, 2026 |
| S-8 | Employee stock plan registration | Jan 28, 2026 | — |
| EFFECT | Filing | Jan 14, 2026 | — |
| 424B3 | Prospectus | Jan 14, 2026 | — |
| 25-NSE | Delisting notice | Jan 14, 2026 | — |
| 10-Q | Quarterly report | Jan 13, 2026 | Nov 30, 2025 |
| S-3 | Shelf registration | Dec 29, 2025 | — |
| D | Filing | Dec 19, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Dec 16, 2025 | Dec 14, 2025 |
| 424B5 | Prospectus supplement | Dec 16, 2025 | — |
| DEF 14A | Proxy statement | Dec 10, 2025 | Jan 27, 2026 |
| EFFECT | Filing | Dec 9, 2025 | — |
| 424B3 | Prospectus | Dec 9, 2025 | — |
| EFFECT | Filing | Dec 8, 2025 | — |
| POS AM | Filing | Dec 5, 2025 | — |
| S-1/A | Amended registration statement | Dec 5, 2025 | — |
| CORRESP | Letter to the SEC | Dec 5, 2025 | — |
| 10-K | Annual report | Nov 28, 2025 | Aug 31, 2025 |
| S-1 | Registration statement | Oct 14, 2025 | — |
| D | Filing | Oct 1, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 29, 2025 | Sep 26, 2025 |
| 424B5 | Prospectus supplement | Sep 29, 2025 | — |
| 8-K |
Current report
Agreement ended
|
Sep 25, 2025 | Sep 19, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 29, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 29, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 29, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 29, 2025 |
| 4 | Insider transaction | Jul 30, 2025 | Jul 29, 2025 |
| 10-Q | Quarterly report | Jul 14, 2025 | May 31, 2025 |
| 8-K |
Current report
Material agreement
|
Jun 12, 2025 | May 14, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 28, 2025 | Apr 24, 2025 |
| 424B5 | Prospectus supplement | Apr 28, 2025 | — |
| 10-Q | Quarterly report | Apr 14, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Material agreement
|
Feb 5, 2025 | Feb 5, 2025 |
| 424B5 | Prospectus supplement | Feb 5, 2025 | — |
| EFFECT | Filing | Jan 30, 2025 | — |
| CORRESP | Letter to the SEC | Jan 28, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 28, 2025 | — |
| S-3 | Shelf registration | Jan 22, 2025 | — |
| 3 | Initial insider ownership | Jan 16, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jan 15, 2025 | Jan 14, 2025 |
| 10-Q | Quarterly report | Jan 10, 2025 | Nov 30, 2024 |
| 4 | Insider transaction | Jan 10, 2025 | Jan 7, 2025 |
| S-8 | Employee stock plan registration | Jan 6, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jan 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement
|
Dec 18, 2024 | Dec 16, 2024 |
| EFFECT | Filing | Dec 17, 2024 | — |
| POS AM | Filing | Dec 16, 2024 | — |
| EFFECT | Filing | Dec 5, 2024 | — |
| 424B3 | Prospectus | Dec 5, 2024 | — |
| CORRESP | Letter to the SEC | Dec 3, 2024 | — |
| 4 | Insider transaction | Dec 3, 2024 | Dec 2, 2024 |
| UPLOAD | Letter from the SEC | Dec 2, 2024 | — |
| DEF 14A | Proxy statement | Nov 27, 2024 | Jan 14, 2025 |
| S-3 | Shelf registration | Nov 26, 2024 | — |
| 10-K | Annual report | Nov 26, 2024 | Aug 31, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| PRE 14A | Preliminary proxy statement | Nov 12, 2024 | Nov 7, 2024 |
| 8-K | Current report | Oct 18, 2024 | Oct 16, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 16, 2024 | Oct 14, 2024 |
| D | Filing | Oct 16, 2024 | — |
| 424B5 | Prospectus supplement | Oct 16, 2024 | — |
| 3 | Initial insider ownership | Oct 2, 2024 | Oct 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2024 | Oct 1, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Sep 23, 2024 | — |
| 3 | Initial insider ownership | Sep 5, 2024 | Aug 31, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 5, 2024 | Aug 31, 2024 |
| 8-K |
Current report
Material agreement
|
Aug 22, 2024 | Aug 21, 2024 |
| 424B5 | Prospectus supplement | Aug 21, 2024 | — |
| 4 | Insider transaction | Aug 13, 2024 | Aug 12, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Aug 6, 2024 | — |
| 4 | Insider transaction | Aug 1, 2024 | Jul 31, 2024 |
| 4 | Insider transaction | Jul 30, 2024 | Jul 26, 2024 |
| 4 | Insider transaction | Jul 30, 2024 | Jul 26, 2024 |
| 4 | Insider transaction | Jul 30, 2024 | Jul 26, 2024 |
| 4 | Insider transaction | Jul 30, 2024 | Jul 26, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 17, 2024 | Jul 15, 2024 |
| 10-Q | Quarterly report | Jul 12, 2024 | May 31, 2024 |
| EFFECT | Filing | Jun 11, 2024 | — |
| 424B3 | Prospectus | Jun 11, 2024 | — |
| CORRESP | Letter to the SEC | Jun 7, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 7, 2024 | — |
| S-1 | Registration statement | Jun 3, 2024 | — |
| 4 | Insider transaction | May 15, 2024 | May 14, 2024 |
| 4 | Insider transaction | May 10, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | May 10, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | May 10, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | May 10, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | May 10, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | May 10, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | May 10, 2024 | Apr 26, 2024 |
| D | Filing | May 2, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Apr 30, 2024 | Apr 30, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Apr 25, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Apr 24, 2024 | Apr 23, 2024 |
| 10-Q | Quarterly report | Apr 9, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 21, 2024 | Mar 15, 2024 |
| EFFECT | Filing | Mar 20, 2024 | — |
| 424B3 | Prospectus | Mar 20, 2024 | — |
| CORRESP | Letter to the SEC | Mar 18, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 18, 2024 | — |
| 3 | Initial insider ownership | Mar 15, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Mar 15, 2024 | Mar 14, 2024 |
| S-1 | Registration statement | Mar 12, 2024 | — |
| DEF 14A | Proxy statement | Mar 6, 2024 | Feb 27, 2024 |
| 8-K |
Current report
Other events
|
Mar 1, 2024 | Feb 29, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Feb 16, 2024 | Feb 14, 2024 |
| D | Filing | Feb 16, 2024 | — |
| 424B5 | Prospectus supplement | Feb 16, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Feb 14, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| 8-K |
Current report
Other events
|
Jan 30, 2024 | Jan 29, 2024 |
| EFFECT | Filing | Jan 26, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 24, 2024 | Jan 24, 2024 |
| POS AM | Filing | Jan 24, 2024 | — |
| S-8 | Employee stock plan registration | Jan 18, 2024 | — |
| 10-Q | Quarterly report | Jan 12, 2024 | Nov 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| EFFECT | Filing | Dec 8, 2023 | — |
| 424B3 | Prospectus | Dec 8, 2023 | — |
| CORRESP | Letter to the SEC | Dec 6, 2023 | — |
| UPLOAD | Letter from the SEC | Dec 6, 2023 | — |
| S-1 | Registration statement | Nov 30, 2023 | — |
| 10-K | Annual report | Nov 20, 2023 | Aug 31, 2023 |
| 8-K |
Current report
Other events
|
Nov 3, 2023 | Nov 3, 2023 |
| 4 | Insider transaction | Nov 1, 2023 | Oct 26, 2023 |
| 4 | Insider transaction | Oct 30, 2023 | Oct 26, 2023 |
| 4 | Insider transaction | Oct 30, 2023 | Oct 26, 2023 |
| 8-K |
Current report
Listing notice
|
Oct 18, 2023 | Oct 17, 2023 |
| 8-K |
Current report
Other events
|
Oct 16, 2023 | Oct 3, 2023 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Oct 12, 2023 | Oct 10, 2023 |
| D | Filing | Oct 4, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 3, 2023 | Sep 28, 2023 |
| 424B5 | Prospectus supplement | Oct 2, 2023 | — |
| SC 13D | Ownership over 5% (active) | Sep 18, 2023 | — |
| 8-K |
Current report
Other events
|
Aug 28, 2023 | Aug 24, 2023 |
| DEF 14A | Proxy statement | Aug 23, 2023 | Aug 8, 2023 |
| PRE 14A | Preliminary proxy statement | Aug 9, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 28, 2023 | Jul 26, 2023 |
| 4 | Insider transaction | Jul 25, 2023 | Jul 25, 2023 |
| 4 | Insider transaction | Jul 25, 2023 | Jul 25, 2023 |
| 4 | Insider transaction | Jul 25, 2023 | Jul 25, 2023 |
| 4 | Insider transaction | Jul 25, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Other events
|
Jul 20, 2023 | Jun 6, 2023 |
| 10-Q | Quarterly report | Jul 14, 2023 | May 31, 2023 |
| 8-K |
Current report
Listing notice
|
Jun 23, 2023 | Jun 22, 2023 |
| 8-K |
Current report
Officer or director change
|
Jun 12, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Material agreement
|
May 12, 2023 | May 12, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
May 10, 2023 | May 8, 2023 |
| 424B4 | Prospectus | May 10, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
May 10, 2023 | May 9, 2023 |
| EFFECT | Filing | May 8, 2023 | — |
| CORRESP | Letter to the SEC | May 5, 2023 | — |
| CORRESP | Letter to the SEC | May 5, 2023 | — |
| CORRESP | Letter to the SEC | May 4, 2023 | — |
| CORRESP | Letter to the SEC | May 4, 2023 | — |
| CORRESP | Letter to the SEC | May 3, 2023 | — |
| CORRESP | Letter to the SEC | May 3, 2023 | — |
| S-1/A | Amended registration statement | Apr 28, 2023 | — |
| 10-Q | Quarterly report | Apr 14, 2023 | Feb 28, 2023 |
| UPLOAD | Letter from the SEC | Apr 7, 2023 | — |
| S-1 | Registration statement | Apr 3, 2023 | — |
| DEF 14A | Proxy statement | Mar 22, 2023 | Mar 17, 2023 |
| PRE 14A | Preliminary proxy statement | Mar 10, 2023 | Mar 3, 2023 |
| 8-K |
Current report
Other events
|
Mar 3, 2023 | Mar 2, 2023 |
| 4 | Insider transaction | Feb 27, 2023 | Feb 9, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 10, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 23, 2023 | Jan 23, 2023 |
| 10-Q/A | Amended quarterly report | Jan 18, 2023 | Nov 30, 2022 |
| 10-Q | Quarterly report | Jan 17, 2023 | Nov 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 17, 2023 | Jan 13, 2023 |
| EFFECT | Filing | Dec 29, 2022 | — |
| POS AM | Filing | Dec 28, 2022 | — |
| EFFECT | Filing | Dec 22, 2022 | — |
| POS AM | Filing | Dec 21, 2022 | — |
| 10-K/A | Amended annual report | Dec 6, 2022 | Aug 31, 2022 |
| 8-K |
Current report
Other events
|
Nov 30, 2022 | Nov 29, 2022 |
| 8-K |
Current report
Auditor change
|
Nov 28, 2022 | Nov 25, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LEXX (Nasdaq)
- Fiscal year ends
- August 31
- Incorporated in
- NV
- Headquarters
- Kelowna, British Columbia, Canada
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1348362
- Former names
- Lexaria Corp. (until May 11, 2016); LEXARIA CORP. (until May 11, 2016)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.